Both in Pharmaceuticals
Atrium Therapeutics vs Sionna Therapeutics
Over the past year RNA returned −87.5% and SION returned −89.9%; their daily moves had a correlation of 0.03.
RNA −87.5% SION −89.9%Growth of $1, one year, split-adjusted
| Metric | RNA | SION |
|---|---|---|
| Price | $8.72 | $3.65 |
| Market cap | $149.2M | $165.0M |
| Today | +1.99% | −2.14% |
| 1 month | +9.4% | −24.7% |
| 6 months | −32.5% | −91.1% |
| Year to date | −87.9% | −91.1% |
| 1 year | — | −90.4% |
| Revenue growth (YoY) | −21.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −672.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.1× | — |
| Net cash | $263.9M | $211.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 103.4% |
| Short % of float | 22.9% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).